Pain and Addiction Committee
Who We Are
The mission of the AAEM Pain and Addiction Committee is providing safe, effective, and efficient analgesia and procedural sedation in the ED and addressing and treating addiction in a patient-centered, evidence-based manner free of commercial bias. This mission is accomplished by dissemination and sharing of knowledge, by creation of pain and addiction management guidelines, by promoting advanced concepts in pain management, sedation, and addiction management, and by multi-specialty collaborations. Our goal is to serve as a forum for AAEM members who share an interest in pain, addiction, and sedation, as well as acting as a liaison between AAEM leadership and issues that arise in these domains.
Objectives
- Collaboration with the Emergency Medical Services Section on a white paper focused on the prehospital use of ketamine.
- Advising the Academy on issues surrounding pain management and addiction medicine and identifying opportunities for advocacy.
- Provide educational content on the most current and relevant topics related to the management of pain and addiction for the benefit of AAEM members and all emergency physicians.
Leadership
Zachary Repanshek, MD FAAEM
Chair
Alexis LaPietra, DO FACEP FAAEM
Vice Chair
Kraftin E. Schreyer, MD MBA FAAEM
Board Liaison
Erica Pollnow
Staff Liaison
Our Projects
-
Management of Opioid Use Disorder in the Emergency Department: A White Paper Prepared for AAEM
Over 2 million Americans misuse prescription or illicitly-obtained opioids, and opioid overdose deaths rose to a record 47,600 in 2017, representing a nearly 600% increase in 18 years. (NCHS 2019, NIH 2019) Because patients with opioid use disorder (OUD) are often socioeconomically and functionally marginalized, the primary point of contact with healthcare for many is […] -
AAEM White Paper on Acute Pain Management in the Emergency Department
AAEM White Paper on Acute Pain Management in the Emergency Department Sergey Motov, MD FAAEM Reuben Strayer, MD FRCP FAAEM Bryan Hayes, PharmD Mark Reiter, MD MBA FAAEM Steven Rosenbaum, MD FAAEM Melanie Richman, MD FAAEM Zachary Repanshek, MD FAAEM Scott Taylor, MBBS Benjamin Friedman, MD FAAEM Effective, efficient, and safe pain management is […]
- A Rose by Any Other Name: Tertiary Prevention for Opioid Use Disorder by Jessica Moore, MD FAAEM, March/April 2024
- The Golden Hour: Buprenorphine Prescribing from the Emergency Department by Jessica Moore, MD, May/June 2023
AAEM, with assistance from the AAEM Pain and Addiction Committee, signed on to a letter today asking Congressional leaders to pass the Mainstreaming Addiction Treatment Act (MAT Act, H.R. 2482, S. 2074).
“In response to the coronavirus pandemic, the twelve undersigned organizations representing behavioral health and substance use disorder treatment providers and public health advocates write to encourage Congress to pass the Mainstreaming Addiction Treatment Act (MAT Act, H.R. 2482, S. 2074). This bipartisan, bicameral legislation would remove the federal barrier established by the DATA 2000 Act that requires health care practitioners to obtain a waiver from Drug Enforcement Administration (DEA) before prescribing buprenorphine, one of three drugs approved by the Food and Drug Administration (FDA) to treat opioid use disorder (OUD)…”
This letter was signed by:
American Academy of Emergency Medicine
American College of Emergency Physicians
American College of Medical Toxicology
American Foundation for Suicide Prevention
Community Catalyst
Drug Policy Alliance
Harm Reduction Coalition
National Association of Attorneys General
National Council for Behavioral Health
National Health Care for the Homeless Council
Shatterproof
The Pew Charitable Trusts
If you are interested in joining our committee, apply today!
Apply to Join a CommitteeAppointments are confirmed on a quarterly basis (January, April, July, October).